FTO and acute myeloid leukemia: FTO reduces the concentration of m6A in mRNA transcripts, regulates the expression of targets such as ASB2 and RARA, and inhibits the differentiation of AML cells induced by ATRA to promote the development of leukemia [40] (Figure 1(c)).